Pharmaceutical Technology13 小时
Dazostinag sodium by Takeda Pharmaceutical for Paranasal Sinus And Nasal Cavity Cancer ...
Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.
Pharmaceutical Technology14 小时
TAK-186 by Takeda Pharmaceutical for Metastatic Colorectal Cancer: Likelihood of Approval
TAK-186 is under clinical development by Takeda Pharmaceutical and currently in Phase II for Metastatic Colorectal Cancer.